Blacksmith Medicines
Latest round
- Seed
Last raised
- Jan 2021
Total raised
- Undisclosed
Investors
- 5
About Blacksmith Medicines
Blacksmith Medicines, Inc.Blacksmith Medicines is dedicated to advancing therapeutic solutions centered on metalloenzyme targeting. Founded in 2017 in San Diego, US, the company was established by Zachary Zimmerman who aims to leverage his expertise in biotechnology.Blacksmith Medicines specializes in the development of innovative therapeutics aimed at targeting human metalloenzymes through a purpose-built platform. The company focuses on creating precision medicines that effectively address various health challenges linked to metalloenzyme dysfunction. These products are designed for therapeutic applications across multiple disease areas, including cancer and neurodegenerative disorders, providing solutions that aim to enhance patient outcomes. Blacksmith Medicines serves a diverse client base that includes pharmaceutical companies, research institutions, and healthcare providers, primarily in North America and Europe.Blacksmith Medicines generates revenue through strategic collaborations and partnerships with pharmaceutical companies and research organizations. The company engages in business-to-business transactions, focusing on licensing agreements and joint development projects that leverage its proprietary technology in metalloenzyme-targeted medicines. Transactions typically involve milestone payments and royalties associated with product development and commercialization.Blacksmith Medicines plans to expand its product offerings with upcoming therapeutics targeting specific metalloenzyme-related health issues, although no specific release dates have been disclosed. The company is also looking to expand into new markets, particularly in Europe and Asia, by 2023.
Who invested in Blacksmith Medicines
5 investors across 1 round
See all investors in Blacksmith Medicines
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jan 8, 2021
Amount
Undisclosed
Investors
Questions about Blacksmith Medicines
Who invested in Blacksmith Medicines?
Blacksmith Medicines has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Blacksmith Medicines raised?
Blacksmith Medicines has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Blacksmith Medicines last raise money?
Blacksmith Medicines's most recent round on record is a Seed, in Jan 2021.
What does Blacksmith Medicines do?
Blacksmith Medicines is a biotechnology company.
Where is Blacksmith Medicines headquartered?
Blacksmith Medicines is headquartered in San Diego, US.
Which VCs invest in companies like Blacksmith Medicines?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Blacksmith Medicines's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Blacksmith Medicines? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.